| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1846 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 198 | 2019 |
| Severe Covid-19 GWAS Group. Genomewide association study of severe Covid-19 with respiratory failure D Ellinghaus, F Degenhardt, L Bujanda, M Buti, A Albillos, P Invernizzi, ... N Engl j Med 383 (16), 1522-1534, 2020 | 135 | 2020 |
| Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion M Riveiro-Barciela, B Mínguez, R Gironés, F Rodriguez-Frías, J Quer, ... Journal of clinical gastroenterology 49 (2), 165-168, 2015 | 123 | 2015 |
| Efficacy of sofosbuvir and velpatasvir, with and without ribavirin, in patients with hepatitis C virus genotype 3 infection and cirrhosis R Esteban, JA Pineda, JL Calleja, M Casado, M Rodríguez, J Turnes, ... Gastroenterology 155 (4), 1120-1127. e4, 2018 | 104 | 2018 |
| Management of direct-acting antiviral agent failures M Buti, M Riveiro-Barciela, R Esteban Journal of Hepatology 63 (6), 1511-1522, 2015 | 94 | 2015 |
| Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs J Llaneras, M Riveiro-Barciela, S Lens, M Diago, A Cachero, ... Journal of hepatology 71 (4), 666-672, 2019 | 88 | 2019 |
| Effectiveness and safety of entecavir or tenofovir in a Spanish cohort of chronic hepatitis B patients: validation of the Page-B score to predict hepatocellular carcinoma M Riveiro-Barciela, D Tabernero, JL Calleja, S Lens, ML Manzano, ... Digestive diseases and sciences 62, 784-793, 2017 | 73 | 2017 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 68* | 2022 |
| Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype M Riveiro-Barciela, M Bes, F Rodríguez-Frías, D Tabernero, A Ruiz, ... Clinical Microbiology and Infection 23 (11), 860-867, 2017 | 64 | 2017 |
| Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection M Riveiro-Barciela, M Buti, M Homs, I Campos-Varela, C Cantarell, ... PloS one 9 (7), e103028, 2014 | 63 | 2014 |
| Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia A Palom, S Rodríguez‐Tajes, CA Navascués, J García‐Samaniego, ... Alimentary pharmacology & therapeutics 51 (1), 158-166, 2020 | 61 | 2020 |
| Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals M Pons, B Santos, M Simón-Talero, M Ventura-Cots, M Riveiro-Barciela, ... Therapeutic Advances in Gastroenterology 10 (8), 619-629, 2017 | 60 | 2017 |
| Effectiveness and safety of sofosbuvir‐based regimens plus an NS 5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real‐life cohort S Alonso, M Riveiro‐Barciela, I Fernandez, D Rincón, Y Real, S Llerena, ... Journal of viral hepatitis 24 (4), 304-311, 2017 | 56 | 2017 |
| Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies? M Riveiro-Barciela, E Muñoz-Couselo, J Fernandez-Sojo, N Diaz-Mejia, ... Journal of hepatology 70 (3), 564-566, 2019 | 54 | 2019 |
| Red blood cell transfusion‐transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report M Riveiro‐Barciela, S Sauleda, J Quer, F Salvador, J Gregori, M Pirón, ... Transfusion 57 (2), 244-247, 2017 | 54 | 2017 |
| Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors M Riveiro‐Barciela, A Barreira‐Díaz, J Vidal‐González, ... Liver International 40 (8), 1906-1916, 2020 | 49 | 2020 |
| Incidences and determinants of functional cure during entecavir or tenofovir disoproxil fumarate for chronic hepatitis B YC Hsu, ML Yeh, GLH Wong, CH Chen, CY Peng, M Buti, M Enomoto, ... The Journal of Infectious Diseases 224 (11), 1890-1899, 2021 | 47 | 2021 |
| Impact of the COVID-19 pandemic on hepatitis B and C elimination: an EASL survey LA Kondili, M Buti, M Riveiro-Barciela, M Maticic, F Negro, T Berg, A Craxì JHEP Reports 4 (9), 100531, 2022 | 45 | 2022 |
